Peter Lopez

Flow cytometry is widely used in cell therapy development but remains difficult to implement in a QC environment workflow. Variability across reagents, instruments, sample preparation and data analysis creates significant risk without thorough technical knowledge about flow cytometry. At the same time, evolving technologies such as spectral cytometry and shifting regulatory expectations are increasing complexity rather than reducing it, leaving many teams uncertain about how to build robust and future-proof approaches.

This workshop provides a practical forum to explore:

• Identifying and controlling sources of variability across reagents, instruments, sample preparation and data analysis
• Harmonizing instruments, antibody panels and reporting across internal and external partners
• Building standardized and reproducible methods that support regulatory confidence and long-term quality control